euportal twitter euportal facebook

A conditional marketing authorisation (CMA) for the COVID‑19 vaccine by BioNTech and Pfizer

health workers korona

21.12.2020 – Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the [...]

Read more